USPTO Examiner PATEL NATASHA - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19002672TRANSCRANIAL ELECTRICAL STIMULATION USING POLY-MODULATED WAVEFORMSDecember 2024October 2025Allow1020YesNo
18909869HEADSET FOR TRANSCRANIAL DIRECT-CURRENT STIMULATION, TDCS, AND A SYSTEM COMPRISING THE HEADSETOctober 2024May 2025Allow710YesNo
18810428SYSTEM AND METHODS FOR RESIDUAL LIMBS OF AMPUTEESAugust 2024September 2025Allow1330YesNo
18806255CAROTID SINUS NERVE STIMULATIONAugust 2024January 2025Allow510NoNo
18653888DEVICES AND METHODS FOR NON-INVASIVE VAGAL NERVE STIMULATIONMay 2024September 2024Allow510NoNo
18442842METHOD AND SYSTEM TO ASSESS DISEASE USING PHASE SPACE VOLUMETRIC OBJECTSFebruary 2024January 2026Abandon2320NoNo
18540162CONTROLLING OR REDUCING STRESS USING AURICULAR NEUROSTIMULATIONDecember 2023December 2024Allow1210NoNo
18386242SYSTEMS AND METHODS FOR TREATING A MEDICAL CONDITIONNovember 2023August 2024Allow920NoNo
18488125SYSTEMS, DEVICES AND METHODS FOR NEUROSTIMULATIONOctober 2023January 2025Allow1510NoNo
18485678IMPLANT TOOL AND IMPROVED ELECTRODE DESIGN FOR MINIMALLY INVASIVE PROCEDUREOctober 2023August 2025Allow2220NoNo
18372099SYSTEM AND APPARATUS FOR INCREASING REGULARITY AND/OR PHASE-LOCKING OF NEURONAL ACTIVITY RELATING TO AN EPILEPTIC EVENTSeptember 2023December 2024Allow1500NoNo
18456130ACOUSTIC OUTPUT DEVICE WITH ANTENNAAugust 2023April 2024Allow820YesNo
18237696DEVICES AND METHODS FOR INTRABODY SURGERYAugust 2023July 2025Abandon2320NoNo
18234108WEARABLE CARDIOVERTER DEFIBRILLATOR LATCHING CONNECTORAugust 2023December 2024Allow1620NoNo
18229379CEREBRAL BLOODFLOW ENHANCEMENTAugust 2023March 2025Abandon1920YesNo
18351247MULTIMODAL TREATMENT OF ALZHEIMER'S DISEASEJuly 2023August 2025Abandon2531YesNo
18343679HEART VALVE DYSFUNCTION DETECTIONJune 2023October 2024Allow1510YesNo
18342590TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) METHOD FOR ALZHEIMERS AND DEMENTIAJune 2023April 2024Allow1000NoNo
18213522DEVICES AND METHODS FOR TREATING EDEMAJune 2023February 2025Allow2020NoNo
18206556NON-INVASIVE NERVE STIMULATION WITH MOBILE SOFTWARE APPLICATIONJune 2023October 2025Abandon2850NoNo
18326237Liquid Embolic Delivery DeviceMay 2023October 2025Allow2840YesNo
18312248CATHETER-BASED DEVICES AND ASSOCIATED METHODS FOR IMMUNE SYSTEM NEUROMODULATIONMay 2023August 2025Allow2730YesNo
18134674CONTROLLER ARRANGEMENTS FOR ROBOTIC SURGICAL SYSTEMSApril 2023November 2025Allow3140YesNo
18185554TREATMENT OF PSYCHIATRIC CONDITIONS SUCH AS RESISTANT DEPRESSION, BIPOLAR DISORDER AND/OR MAJOR DEPRESSIVE DISORDER VIA APPLICATION OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION WITH THYROID HORMONE TREATMENT AND/OR QUETIAPINEMarch 2023July 2025Abandon2830YesNo
18121013OSTOMY APPLIANCE HAVING AN ELECTRICAL CONNECTORMarch 2023August 2024Allow1710NoNo
18164946METHOD AND APPARATUS FOR CONTROLLING MULTI-SITE NEUROSTIMULATIONFebruary 2023January 2025Abandon2310NoNo
18153638POWER AND DATA TRANSFER IN HEARING PROSTHESESJanuary 2023November 2024Allow2210NoNo
18095046COUNTERPULSATION DEVICE DRIVER APPARATUS, METHOD AND SYSTEMJanuary 2023December 2024Allow2310NoNo
18095475BIOSTIMULATOR HAVING LOCKABLE FIXATION ELEMENTJanuary 2023September 2024Allow2010YesNo
18084345SYSTEMS AND METHODS FOR HEART FAILURE MANAGEMENTDecember 2022June 2025Allow3040YesNo
18059503NONINVASIVE CRANIAL NERVE THERAPYNovember 2022March 2025Allow2720YesNo
17994988BIOSTIMULATOR HAVING COAXIAL FIXATION ELEMENTSNovember 2022August 2024Allow2110YesNo
17966190NEUROSTIMULATION-BASED NEUROFEEDBACK DEVICE USING BRAIN WAVES AND HEARTBEAT SIGNALSOctober 2022January 2026Allow3920YesNo
18046611SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPSOctober 2022February 2024Allow1630YesNo
17936986SYSTEMS AND METHODS FOR DETECTING MOTONEURON EXCITABILITYSeptember 2022September 2025Allow3510NoNo
17905428MEDICAL TREATMENT DEVICE AND METHOD FOR STIMULATING NEURONS OF A PATENT TO SUPPRESS A PATHOLOGICALLY SYNCHRONOUS ACTIVITY THEREOFSeptember 2022June 2025Allow3410NoNo
17901404DELIVERY OF IMPLANTABLE NEUROSTIMULATORSSeptember 2022January 2026Allow4140YesNo
17883905Methods and Systems for Controlling Blood PressureAugust 2022December 2023Allow1610YesNo
17865836WIRELESS POWER RECEIVER COIL FOR NEUROMODULATION DEVICEJuly 2022June 2024Allow2321YesNo
17858151DEVICES AND METHODS FOR NON-INVASIVE VAGAL NERVE STIMULATIONJuly 2022September 2024Abandon2610NoNo
17790573SYSTEMS AND METHODS FOR STIMULATION OF CRANIAL NERVESJuly 2022September 2023Allow1520YesNo
17844960ACOUSTIC OUTPUT DEVICE WITH ANTENNAJune 2022July 2023Allow1321NoNo
17844368SYSTEMS AND METHODS FOR ENHANCING NEUROSTRUCTURAL DEVELOPMENTJune 2022January 2024Abandon1931NoNo
17843732MESH INTRODUCTION CARTRIDGES AND METHODS OF ASSISTED MESH PLACEMENT FOR SURGICAL ROBOTICSJune 2022October 2025Abandon4020NoNo
17842221NON-INVASIVE STIMULATION SYSTEM FOR SYNCHRONOUS STIMULATION OF STERNOCLEIDOMASTOID MUSCLES AND CUTANEOUS CERVICAL NERVE BRANCHES WITH AUTONOMIC CONNECTIONSJune 2022August 2025Allow3820NoNo
17750109DEVICES AND METHODS FOR TREATING STRESS AND IMPROVING ALERTNESS USING ELECTRICAL STIMULATIONMay 2022April 2024Abandon2340YesNo
17744217IMPLANTABLE MEDICAL DEVICES, SYSTEMS AND METHODS FOR REDUCING T-WAVE OVERSENSING AND ARRHYTHMIA UNDERSENSINGMay 2022June 2025Allow3711NoNo
17734819SYSTEMS AND METHODS FOR DETERMINING CARDIAC PERFORMANCEMay 2022August 2024Allow2711YesNo
17768298SURGICAL TOOL WITH NESTED SHAFT TUBESApril 2022August 2024Allow2900NoNo
17714225DELIVERY OF SOMATOSENSATION FOR MEDICAL DIAGNOSTICS OR GUIDING MOTOR ACTIONApril 2022March 2023Allow1230NoNo
17694655NON-INVASIVE NERVE STIMULATION WITH MOBILE DEVICEMarch 2022February 2023Allow1220YesNo
17651046PERIPHERAL NERVE STIMULATION DEVICE FOR AFFECTING PARASYMPATHETIC AND SYMPATHETIC ACTIVITY TO ACHIEVE THERAPEUTIC EFFECTSFebruary 2022March 2024Abandon2531NoNo
17585295Adaptive Speed Control Algorithms and Controllers for Optimizing Flow in Ventricular Assist DevicesJanuary 2022January 2024Allow2420NoNo
17565676ACOUSTIC OUTPUT DEVICE WITH ANTENNADecember 2021July 2022Allow611NoNo
17566055WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) WITH ECG PREAMP HAVING ACTIVE INPUT CAPACITANCE BALANCINGDecember 2021February 2024Allow2610NoNo
17556176DEVICE AND METHODS FOR TARGETED TISSUE DRUG DELIVERYDecember 2021January 2024Abandon2510NoNo
17540602END-EFFECTORS FOR SURGICAL ROBOTIC SYSTEMS HAVING SEALED OPTICAL COMPONENTSDecember 2021January 2025Allow3730NoNo
17535296SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPSNovember 2021July 2022Allow811YesNo
17535242SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPSNovember 2021April 2023Allow1631YesNo
17524225PASSIVE PUMPNovember 2021March 2022Allow501NoNo
17522010NON-INVASIVE NERVE STIMULATION WITH MOBILE DEVICENovember 2021December 2023Allow2560NoNo
17512156SYSTEMS FOR ELECTRICAL STIMULATIONOctober 2021March 2024Allow2910NoNo
17498390METHOD FOR CALIBRATION OF TRANSCUTANEOUS NERVE STIMULATOROctober 2021July 2023Allow2100NoNo
17495566DEVICES AND METHODS FOR INTRABODY SURGERYOctober 2021June 2023Allow2101NoNo
17483196Bio-Inspired Fast Fitting of Cochlear ImplantsSeptember 2021March 2025Allow4140NoNo
17479784LEAD PLACEMENT FOR NERVE STIMULATIONSeptember 2021May 2024Allow3230YesNo
17475516DEVICES AND METHODS FOR INTRABODY SURGERYSeptember 2021June 2023Allow2110YesNo
17472603LIGHT TOUCH THERAPEUTIC EARBUDSSeptember 2021December 2024Abandon3910NoNo
17472353METHOD AND SYSTEM TO ASSESS DISEASE USING PHASE SPACE VOLUMETRIC OBJECTSSeptember 2021November 2023Allow2600NoNo
17459592EXPANDABLE ELECTROPORATION DEVICES AND METHODS OF USEAugust 2021October 2024Allow3821YesNo
17410514DELIVERY OF IMPLANTABLE NEUROSTIMULATORSAugust 2021June 2022Allow1020NoNo
17405287ACOUSTIC OUTPUT DEVICE WITH ANTENNAAugust 2021June 2024Allow3340NoNo
17379905PERIPHERAL NERVE STIMULATION DEVICE FOR AFFECTING PARASYMPATHETIC AND SYMPATHETIC ACTIVITY TO ACHIEVE THERAPEUTIC EFFECTSJuly 2021August 2022Abandon1320YesNo
17372487APPARATUS AND METHODS FOR OPTIMIZING INTRA CARDIAC FILLING PRESSURES, HEART RATE, AND CARDIAC OUTPUTJuly 2021September 2024Allow3831YesNo
17358738USE AND MONITORING OF INHALED NITRIC OXIDE WITH LEFT VENTRICULAR ASSIST DEVICESJune 2021May 2023Allow2220YesNo
17355225COCHLEAR IMPLANTS, MAGNETS FOR USE WITH SAME AND MAGNET RETROFIT METHODSJune 2021August 2023Allow2610NoNo
17355092SYSTEMS AND METHODS FOR DETERMINING OPTIMAL TEMPORAL PATTERNS OF NEURAL STIMULATIONJune 2021March 2025Allow4550YesNo
17415508APPARATUS AND METHOD FOR MICROCURRENT STIMULATION THERAPYJune 2021May 2023Abandon2342YesNo
17346266SYSTEMS AND METHODS FOR TREATING A MEDICAL CONDITION WITH AN ELECTRICAL STIMULATION TREATMENT REGIMENJune 2021August 2023Allow2660YesNo
17345858IMPLANT TOOL AND IMPROVED ELECTRODE DESIGN FOR MINIMALLY INVASIVE PROCEDUREJune 2021July 2023Allow2500NoNo
17336556NON-VERBAL COMMUNICATIONS RADIO AND NON-VERBAL COMMUNICATION SYSTEM USING A PLURALITY OF NONVERBAL COMMUNICATION RADIOSJune 2021February 2022Allow811NoNo
17316090MODULAR MAMMALIAN BODY IMPLANTABLE FLUID FLOW INFLUENCING DEVICE AND RELATED METHODSMay 2021March 2024Allow3411YesNo
17313052TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODSMay 2021January 2025Allow4440NoNo
17246937SYSTEM AND APPARATUS FOR AUTOMATED QUANTITATIVE ASSESSMENT, OPTIMIZATION AND LOGGING OF THE EFFECTS OF A THERAPYMay 2021August 2023Allow2710NoNo
17244573Aortic Connectors and Methods of UseApril 2021June 2023Allow2610YesNo
17237080System and method for maneuvering a data acquisition device based on image analysisApril 2021November 2023Abandon3010NoNo
17220805NON-INVASIVE VAGUS NERVE STIMULATIONApril 2021December 2021Allow820NoNo
17182543SYSTEM AND APPARATUS FOR INCREASING REGULARITY AND/OR PHASE-LOCKING OF NEURONAL ACTIVITY RELATING TO AN EPILEPTIC EVENTFebruary 2021June 2023Allow2801NoNo
17177968LEADLESS CARDIAC STIMULATION DEVICE EMPLOYING DISTRIBUTED LOGICFebruary 2021June 2023Allow2820NoNo
17156896CAROTID SINUS NERVE STIMULATIONJanuary 2021June 2024Allow4120YesNo
17142536PHYSIOLOGICAL MONITORING METHODS AND SYSTEMS UTILIZING DISTRIBUTED ALGORITHMSJanuary 2021July 2023Allow3010NoNo
17253298SYSTEM AND METHOD FOR BRAINWAVE STIMULATION USING ALTERED NATURAL STIMULIDecember 2020September 2023Abandon3320YesNo
17116233TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEMDecember 2020November 2023Allow3531YesNo
17113232DIRECTIONAL DEVICE FOR EPIDURAL NEEDLEDecember 2020February 2024Allow3810NoNo
17113460SYSTEMS AND METHODS FOR THE TREATMENT OF PAIN THROUGH NEURAL FIBER STIMULATIONDecember 2020February 2025Allow5050YesNo
17108210SYSTEM AND METHOD EMPLOYING INTERFERENTIAL ELECTRICAL STIMULATION FOLLOWING SHOULDER SURGERYDecember 2020March 2021Allow310NoNo
16953449SYSTEMS AND METHODS FOR PERFORMING A TISSUE SEALNovember 2020November 2023Allow3621YesNo
16952100METHOD FOR GENERATING STIMULATION PARAMETERS, ELECTRICAL STIMULATION CONTROL APPARATUS AND ELECTRICAL STIMULATION SYSTEMNovember 2020May 2023Allow3020NoNo
17056506NONINVASIVE CRANIAL NERVE THERAPYNovember 2020June 2022Allow1910YesNo
17086507METHOD AND SYSTEM TO DETECT P-WAVES IN CARDIAC ARRHYTHMIC PATTERNSNovember 2020July 2023Allow3310NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PATEL, NATASHA.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
0
(0.0%)
Examiner Reversed
2
(100.0%)
Reversal Percentile
99.7%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
6
Allowed After Appeal Filing
2
(33.3%)
Not Allowed After Appeal Filing
4
(66.7%)
Filing Benefit Percentile
55.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner PATEL, NATASHA - Prosecution Strategy Guide

Executive Summary

Examiner PATEL, NATASHA works in Art Unit 3792 and has examined 329 patent applications in our dataset. With an allowance rate of 85.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner PATEL, NATASHA's allowance rate of 85.4% places them in the 62% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PATEL, NATASHA receive 1.90 office actions before reaching final disposition. This places the examiner in the 46% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PATEL, NATASHA is 30 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +8.1% benefit to allowance rate for applications examined by PATEL, NATASHA. This interview benefit is in the 38% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 34.0% of applications are subsequently allowed. This success rate is in the 75% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 51.8% of cases where such amendments are filed. This entry rate is in the 78% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 71.4% of appeals filed. This is in the 60% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 42.1% are granted (fully or in part). This grant rate is in the 34% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.8% of allowed cases (in the 73% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 58% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.